Gaurav Aggarwal

Dr. Aggarwal joined Ocera Therapeutics as Chief Business Officer in April 2014. Previously Dr. Aggarwal was a life sciences venture capital investor, serving as a Managing Director of Investor Growth Capital, a Partner at Panorama Capital, and an associate with JPMorgan Partners.  Prior to joining JPMorgan Partners, Dr. Aggarwal was employed by KBL Healthcare Ventures, and completed an analyst program at Wasserstein Perella & Co. Dr. Aggarwal has served on the board of directors of several companies including Alvine Pharmaceuticals, Aupsex Pharmaceuticals, FlowCardia, Hyperion Therapeutics, NextWave Pharmaceuticals and PIramed. Dr. Aggarwal received his M.D. from Columbia University, College of Physicians & Surgeons, and his B.S. in Agricultural Economics from Cornell University.